Laura Dirkx Selected Research

Dexamethasone (Maxidex)

1/2022

Reprogramming of glucocorticoid receptor function by hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Dirkx Research Topics

Disease

4	Infections 01/2023 - 01/2020
2	Leishmaniasis 12/2022 - 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	African Trypanosomiasis (Nagana) 12/2022
1	Inflammation (Inflammations) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Firefly LuciferasesIBA 12/2022 - 01/2021
1	EnzymesIBA 01/2023
1	Poly dA-dT (dT, Poly dA)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	InterferonsIBA 01/2023
1	D-luciferinIBA 12/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	LipopolysaccharidesIBA 01/2022
1	miltefosine (Impavido)IBA 01/2021
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 01/2021
1	fluorescent protein 583IBA 01/2021
1	Red Fluorescent ProteinIBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Sialic Acid Binding Ig-like Lectin 1IBA 01/2020

Therapy/Procedure

1	Therapeutics 01/2023